Yahoo · Sep 17, 2026
Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio for Now
XRAY's digital dentistry, R&D and restructuring support growth, but CAD/CAM, implants, SureSmile and tariff pressures pose near-term risks.
NASDAQ · XRAY
DENTSPLY SIRONA Inc.
Healthcare · Medical - Instruments & Supplies
$9.40
Down-$0.13 (-1.36%)
Updated Sep 26, 2026, 2:55 PM
SID Score
4.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 2.31B
- P/E ratio
- -2.62
- Dividend yield
- 6.81%
- 52-week range
- $9.29 – $14.76
- Volume
- 4.89M
- Avg. volume
- 3.53M
Price performance
XRAY price history
1M range · 20 trading sessions · Daily adjusted prices
XRAY closed at $9.40 after 20 trading sessions, down 15.47% for the selected period.
- Last close
- $9.40
- Period change
- -15.47%
- Period low
- $9.38
- Period high
- $11.43
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 25, 2026 | $9.52 | $9.625 | $9.29 | $9.40 | 4.89M |
| Sep 24, 2026 | $9.76 | $9.81 | $9.48 | $9.53 | 3.74M |
| Sep 23, 2026 | $9.89 | $10.00 | $9.74 | $9.78 | 3.35M |
| Sep 22, 2026 | $9.655 | $10.02 | $9.65 | $9.95 | 5.13M |
| Sep 21, 2026 | $9.57 | $9.64 | $9.41 | $9.44 | 6.65M |
| Sep 18, 2026 | $9.38 | $9.64 | $9.37 | $9.54 | 8.47M |
| Sep 17, 2026 | $10.11 | $10.12 | $9.36 | $9.375 | 9.31M |
| Sep 16, 2026 | $9.80 | $10.29 | $9.80 | $10.14 | 5.51M |
| Sep 15, 2026 | $10.28 | $10.385 | $9.81 | $9.83 | 4.9M |
| Sep 14, 2026 | $10.47 | $10.6165 | $10.345 | $10.38 | 3.21M |
| Sep 11, 2026 | $10.67 | $10.72 | $10.28 | $10.46 | 3.25M |
| Sep 10, 2026 | $10.65 | $10.65 | $10.39 | $10.50 | 3.45M |
| Sep 9, 2026 | $10.89 | $10.94 | $10.63 | $10.72 | 3.23M |
| Sep 8, 2026 | $11.24 | $11.28 | $10.935 | $10.99 | 3.16M |
| Sep 4, 2026 | $11.29 | $11.53 | $11.195 | $11.38 | 2.6M |
| Sep 3, 2026 | $11.51 | $11.715 | $11.13 | $11.43 | 3.93M |
| Sep 2, 2026 | $10.89 | $11.55 | $10.83 | $11.29 | 4.61M |
| Sep 1, 2026 | $11.16 | $11.26 | $10.735 | $10.76 | 3.58M |
| Aug 31, 2026 | $11.185 | $11.225 | $10.89 | $11.17 | 4.43M |
| Aug 28, 2026 | $11.165 | $11.29 | $11.05 | $11.12 | 2.97M |
Latest XRAY news
The latest Smart Investors Daily articles mentioning XRAY.
Stock researchCompany · Overview
XRAY research
Overview
Company profile and research snapshot.
Company profile
Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is sold to labs and offices through the firm's salesforce or directly to consumers (such as the Byte clear aligner).
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Hold
- Average target
- $15.33
- Implied upside
- —
- Analysts
- 21
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 17, 2026 | BMO Capital | Market Perform | — |
| Aug 24, 2026 | Barclays | Underweight | — |
| Jul 29, 2026 | Piper Sandler | Neutral | — |
| Jul 9, 2026 | BMO Capital | Market Perform | — |
| Jun 4, 2026 | Barclays | Underweight | — |
News briefing
No generated briefing is available yet.
Benzinga · Sep 17, 2026
BMO Capital Maintains Market Perform on Dentsply Sirona, Lowers Price Target to $10
BMO Capital analyst Vik Chopra maintains Dentsply Sirona (NASDAQ:XRAY) with a Market Perform and lowers the price target from $13 to $10.
Yahoo · Sep 8, 2026
XRAY's Q2 Earnings Beat Meets Steady Guidance and Margin Pressure
XRAY beat Q2 earnings and revenue estimates, held 2026 guidance and improved cash flow, but falling sales and margin pressure cloud the recovery.
Yahoo · Sep 4, 2026
DENTSPLY SIRONA (XRAY) Returns To Profit As Investors Weigh Its Valuation
DENTSPLY SIRONA (XRAY) shares are in focus after the company reported second quarter 2026 results that returned the business to profitability while net sales declined 4.1% year over year. The latest results and upcoming appearance at the Baird 2026 Global Healthcare Conference come after a mixed share price pattern for DENTSPLY SIRONA, with a 7 day share price return of 3.53% but a 30 day share price return that declined 19.90%. Recent momentum has been choppy, as a 90 day share price return...
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
